Efficacy of the neutralizing antibodies after the booster dose on SARS-CoV-2 Omicron variant and a two-year longitudinal antibody study on Wild Type convalescents

OBJECTIVES: Waning vaccine-induced immunity and emergence of new severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants which may lead to immune escape, pose a major threat to the COVID-19 pandemic. Currently, enhanced efficacy of the neutralization antibodies (NAb) produced after the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yufen, Pan, Juan, Jin, Minya, Wang, Jing, Tung, Tao-Hsin, Chen, Shiyong, Bi, Xiaojie, Zhou, Kai, Chen, Mengyuan, Wang, Donglian, Li, Jun, Shen, Bo, Ying, Lingjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University. Published by Elsevier B.V. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073579/
https://www.ncbi.nlm.nih.gov/pubmed/37044040
http://dx.doi.org/10.1016/j.intimp.2023.110151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073579/
https://www.ncbi.nlm.nih.gov/pubmed/37044040
http://dx.doi.org/10.1016/j.intimp.2023.110151

Ejemplares similares